Oral birch pollen immunotherapy with apples: Results of a phase II clinical pilot study

BACKGROUND: Seventy percent of patients suffering from birch pollen allergy (BPA) develop a pollen‐related food allergy (prFA), especially to apples, due to a clinically relevant cross‐reactivity between the major allergen in birch Bet v 1 and Mal d 1 in apples. Therefore allergen‐specific immunothe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Immun Inflamm Dis
Autori principali: Nothegger, Bettina, Reider, Norbert, Covaciu, Claudia E., Cova, Valentina, Ahammer, Linda, Eidelpes, Reiner, Unterhauser, Jana, Platzgummer, Stefan, Raffeiner, Elisabeth, Tollinger, Martin, Letschka, Thomas, Eisendle, Klaus
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2021
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8127540/
https://ncbi.nlm.nih.gov/pubmed/33621436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.410
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi